GLOBALT Investments LLC GA Has $3.35 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GLOBALT Investments LLC GA lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 656.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,809 shares of the medical equipment provider's stock after buying an additional 5,909 shares during the quarter. GLOBALT Investments LLC GA's holdings in Intuitive Surgical were worth $3,345,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. M&G Plc purchased a new stake in Intuitive Surgical during the first quarter valued at $1,318,000. TIAA Trust National Association raised its stake in Intuitive Surgical by 26.6% during the first quarter. TIAA Trust National Association now owns 2,729 shares of the medical equipment provider's stock valued at $1,089,000 after purchasing an additional 573 shares in the last quarter. Penobscot Investment Management Company Inc. raised its stake in Intuitive Surgical by 3.2% during the first quarter. Penobscot Investment Management Company Inc. now owns 2,430 shares of the medical equipment provider's stock valued at $970,000 after purchasing an additional 75 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in Intuitive Surgical by 20.5% during the first quarter. O Shaughnessy Asset Management LLC now owns 29,231 shares of the medical equipment provider's stock valued at $11,666,000 after purchasing an additional 4,973 shares in the last quarter. Finally, UniSuper Management Pty Ltd raised its stake in Intuitive Surgical by 157.6% during the first quarter. UniSuper Management Pty Ltd now owns 7,250 shares of the medical equipment provider's stock valued at $2,893,000 after purchasing an additional 4,436 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In other Intuitive Surgical news, insider Jamie Samath sold 269 shares of the company's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 188 shares of the company's stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $482.21, for a total value of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares of the company's stock, valued at approximately $2,655,048.26. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 91,178 shares of company stock worth $45,897,071 over the last 90 days. 0.90% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on ISRG shares. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a "buy" rating in a research report on Friday, October 18th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an "overweight" rating in a report on Friday, October 18th. Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an "outperform" rating in a report on Friday, October 18th. Finally, Raymond James increased their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $524.61.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $5.42 during midday trading on Monday, hitting $533.03. 682,988 shares of the company were exchanged, compared to its average volume of 1,457,795. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $544.38. The company's fifty day moving average price is $499.29 and its 200-day moving average price is $458.50. The company has a market cap of $189.85 billion, a PE ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.